Alemtuzumab induction for retransplantation after primary transplant with alemtuzumab induction 
.

CONCLUSION: Patients with repeat courses of ALEM induction across multiple transplants may have a higher incidence of fungal infection. Future studies are needed to explore this risk, particularly in light of current drug manufacturer allocation practices and potential increased utilization by transplant centers.
.
PMID: 31670651 [PubMed - as supplied by publisher]

Source: Clinical Nephrology - October 30, 2019 Category: Urology & Nephrology Authors: Descourouez JL, Jorgenson MR, Parajuli S, Mandelbrot DA, Leverson GE, Odorico JS, Redfield RR Tags: Clin Nephrol Source Type: research